Efficacy of Acceptance and Commitment Therapy for the Management of Quality of Life in Patients Post Myocardial Infarction

NCT06548282 | Completed DMC

• 1 other identifier: FJWU/EC/2024/88
• Study Type: interventional
• Target: 60
• Locations: 1 country
• Sites: 2

Brief Summary

The present study aims to investigate the efficacy of acceptance and commitment therapy for the management of quality of life in patients post-myocardial infarction

Conditions

Psychological Distress; Type D Personality; Medication Adherence; Quality of Life

Outcome Measures

Primary Outcomes (1)

• World Health Organization Quality of Life Scale Urdu Version

  It has 26 items and four domains: physical health (7 items), psychological health (6 items), social relationships (3 items), and environmental health (8 items); it also contains quality of life and general health items. The minimum value is 26 and the maximum value is 130. Higher scores on the scale indicate higher quality of life and low scores indicate low quality of life.

  3 months

Study Arms (2)

Experimental

EXPERIMENTAL

Who receives intervention i.e. Acceptance and Commitment Therapy

Other: Acceptance and commitment therapy

Waitlist Control

ACTIVE COMPARATOR

Who would receive intervention after study completion

Other: Acceptance and commitment therapy

Interventions

Acceptance and commitment therapy OTHER

Introduction: Build rapport and complete pre-assessment questionnaires. First Session: Introduce therapist, ACT principles, and MI complications. Provide psychoeducation and assign homework. Second Session: Review feedback and encourage change. Assign homework. Third Session: Discuss acceptance and coping strategies. Assign homework. Fourth Session: Discuss cognitive diffusion and unhelpful thoughts. Assign homework. Fifth Session: Explore self-concept and mindfulness. Assign homework. Sixth Session: Identify and elaborate on values. Assign homework. Seventh Session: Discuss values, goals, and barriers. Assign homework. Eighth Session: Discuss commitment to action and relapse prevention. Administer post-test and express gratitude.

Experimental; Waitlist Control

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• First-time diagnosed, non-hospitalized patients with myocardial infarction (MI).
• Patients attending follow-up visits at the hospital.
• Patients experiencing distress.
• Patients exhibiting features of Type D personality.
• Patients reporting low levels of:
• Quality of Life (QoL)
• Medication adherence
• Social support
• Acceptance
• Psychological flexibility
• Patients aged 18 years and above.
• Both genders.
• Patients who can understand Urdu.
• Patients who can provide informed consent.

You may not qualify if:

• Hospitalized patients with myocardial infarction (MI).
• Patients with myocardial infarction (MI) and other chronic co-morbid diseases, such as:
• Cancer
• Cognitive deficits
• Chronic psychological disorders
• Patients with silent myocardial infarction.
• Patients younger than 18 years.

Sponsors & Collaborators

• Fatima Jinnah Women University: lead

Study Sites (2)

Armed Forces Institute of Cardiology

Rawalpindi, Punjab Province, 46000, Pakistan

Location

Rawalpindi Institute of Cardiology

Rawalpindi, Punjab Province, 46000, Pakistan

Location

MeSH Terms

Conditions

Medication Adherence

Interventions

Acceptance and Commitment Therapy

Condition Hierarchy (Ancestors)

Patient Compliance; Patient Acceptance of Health Care; Treatment Adherence and Compliance; Health Behavior; Behavior

Intervention Hierarchy (Ancestors)

Cognitive Behavioral Therapy; Behavior Therapy; Psychotherapy; Behavioral Disciplines and Activities

Study Officials

• Sehrish Khan, PhD Scholar

  Fatima Jinnah women University, Rawalpindi, Pakistan

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: DOUBLE
• Who Masked: PARTICIPANT, INVESTIGATOR
• Purpose: HEALTH SERVICES RESEARCH
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Study Record Dates

• First Submitted: August 7, 2024
• First Posted: August 12, 2024
• Study Start: June 21, 2024
• Primary Completion: September 21, 2024
• Study Completion: September 21, 2024
• Last Updated: March 4, 2025

Record last verified: 2025-03

Locations

PA (2)